Label-free detection of β-amyloid peptides (Aβ40 and Aβ42): a colorimetric sensor array for plasma monitoring of Alzheimer's disease
- 21 March 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 10 (14) , 6361-6368
Abstract
Monitoring the ratio of 40- and 42-residue amyloid β peptides (i.e., Aβ40 and Aβ42) in human plasma is considered one of the hallmarks of detection of the early stage of Alzheimer's disease (AD). Therefore, development of a specific, yet non-antibody-based method for simultaneous detection of Aβ40 and Aβ42 may have considerable clinical applications. Here, we developed a ‘nanoparticle-based colorimetric sensor array’ utilizing label-free gold and silver nanoparticles for visual detection of Aβ42 and Aβ40. Different aggregation behaviors of nanoparticles through their conjugation with Aβ42 and Aβ40 followed by the coordination of Aβ42 and Aβ40 with Cu(II) led to diverse spectral and color changes. The spectral changes were quantitatively differentiated by a supervised pattern recognition approach, linear discriminant analysis (LDA). The proposed sensor array was able to discriminate among Aβ42, Aβ40, and HSA in different concentrations (50 nmol L−1 to 500 nmol L−1) and their mixtures. Moreover, the sensor array had the capability to identify structurally similar Aβ peptides in human plasma samples. The developed sensor array technology might pave the way for a cheap and rapid, yet robust, platform for high-throughput screening of human plasma for defining the at-risk population for AD.Keywords
Funding Information
- Sharif University of Technology
- Iran National Science Foundation (96009237)
This publication has 52 references indexed in Scilit:
- A carbon nanotube metal semiconductor field effect transistor-based biosensor for detection of amyloid-beta in human serumBiosensors and Bioelectronics, 2013
- Studies on the Interactions of Copper and Zinc Ions with β-Amyloid Peptides by a Surface Plasmon Resonance BiosensorInternational Journal of Molecular Sciences, 2012
- The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and FibrillizationChemical Reviews, 2012
- Microbiosensor for Alzheimer’s disease diagnostics: detection of amyloid beta biomarkersJournal of Neurochemistry, 2012
- Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive DeclineJAMA, 2011
- Regenerable and Simultaneous Surface Plasmon Resonance Detection of Aβ(1−40) and Aβ(1−42) Peptides in Cerebrospinal Fluids with Signal Amplification by Streptavidin Conjugated to an N-Terminus-Specific AntibodyAnalytical Chemistry, 2010
- Ten-Year Change in Plasma Amyloid β Levels and Late-Life Cognitive DeclineArchives of Neurology, 2009
- Ultrasensitive and Highly Selective Detection of Alzheimer’s Disease Biomarker Using Two-Photon Rayleigh Scattering Properties of Gold NanoparticleACS Nano, 2009
- Turkevich Method for Gold Nanoparticle Synthesis RevisitedThe Journal of Physical Chemistry B, 2006
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyThe Lancet Neurology, 2006